drugset / Trial / NCT02562521

A Smoking Cessation Intervention for Yale Dining Employees

NCT02562521

Phase 4 Completed 25 enrolled Yale University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate a smoking cessation program for employees at the Yale University dining hall. Two pilot dining halls and six paired dining halls (3 test and 3 control sites) will be offered a contingency management/pharmacotherapy smoking cessation intervention at the work site.

Timeline

Start
2015-09
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown
Subject Varenicline Small molecule

Indications

No indication recorded.